Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy

Ling, Victoria, Burnett, Alan Kenneth, Bradstock, Ken, Seymour, John F., Hills, Robert Kerrin and Wei, Andrew 2013. Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy. British Journal of Haematology 160 (6) , pp. 861-863. 10.1111/bjh.12178

Full text not available from this repository.

Official URL: http://dx.doi.org/10.1111/bjh.12178

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Publisher:	Wiley-Blackwell
ISSN:	0007-1048
Last Modified:	19 Oct 2019 02:57
URI:	http://orca-mwe.cf.ac.uk/id/eprint/49806

Citation Data

Cited 6 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item

Altmetric

Altmetric

Altmetric